11/19/2024 8:31 PM | Boxer Capital Management, LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/14/2024 4:52 PM | Tada Hiroomi (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 4:47 PM | NEXTECH VI ONCOLOGY SCSP (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/14/2024 3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/13/2024 5:04 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/12/2024 9:34 AM | FMR LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/08/2024 3:43 PM | Kjellson Nina S (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/06/2024 6:24 PM | Kjellson Nina S (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 5:18 PM | Kjellson Nina S (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 3:22 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 4:15 PM | Tada Hiroomi (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024 6:00 AM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 7:01 AM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/22/2024 8:15 PM | Boxer Capital Management, LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024 7:47 PM | Boxer Capital Management, LLC (Reporting) Tyra Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/22/2024 7:49 PM | Boxer Capital Management, LLC (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/22/2024 4:11 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024 4:13 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/22/2024 4:04 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:23 PM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 7:12 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 4:51 PM | Harris Todd (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 8:59 PM | Boxer Capital, LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/15/2024 6:22 PM | Boxer Asset Management Inc. (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/02/2024 4:38 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 5:44 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 5:24 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 3:49 PM | Harris Todd (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 3:42 PM | Harris Todd (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 2:56 PM | Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 2:59 PM | Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 3:05 PM | Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 2:27 PM | Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024 4:12 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:15 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 3:49 PM | Tyra Biosciences (Issuer) Warner Douglas J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/10/2024 3:53 PM | Tyra Biosciences (Issuer) Warner Douglas J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 4:50 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 4:55 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 4:18 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:10 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Breaking News: Tesla headed to $500… (Ad) That headline hit late last night…and the rally has begun
Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. |
06/07/2024 2:08 PM | Bensen Daniel (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 5:26 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Kjellson Nina S (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | MORE ROBERT J (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | KAPLAN GILLA (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Subramony Siddarth (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Tyra Biosciences (Issuer) Verjee Rehan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Simson Jake (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:46 PM | Rothenberg Stephen Michael (Reporting) Tyra Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 3:48 PM | Rothenberg Stephen Michael (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:49 PM | Moran Susan (Reporting) Tyra Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 3:49 PM | Moran Susan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:08 PM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2024 11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
04/05/2024 3:20 PM | Tyra Biosciences (Filer)
| Form PRE 14A | |
03/19/2024 6:58 PM | Tada Hiroomi (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:01 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:38 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 3:33 PM | Tyra Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/19/2024 3:35 PM | Tyra Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024 4:46 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:19 AM | FMR LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
03/08/2024 4:38 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:40 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:58 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:00 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:24 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/09/2024 6:26 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/08/2024 4:10 PM | Boxer Capital, LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/08/2024 4:16 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:09 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:22 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:23 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 3:56 PM | Bensen Daniel (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:40 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/05/2024 5:05 AM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 4:04 PM | Bensen Daniel (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:47 PM | Harris Todd (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 4:24 PM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 8:00 AM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |